Breaking News Instant updates and real-time market news.

BLU

Bellus Health

$6.49

0.24 (3.84%)

08:39
09/30/19
09/30
08:39
09/30/19
08:39

Jefferies sees potential double in Bellus Health, starts shares at Buy

Jefferies analyst Suji Jeong initiated coverage of Bellus Health with a Buy rating and $20 price target. The company is developing BLU-5937 for chronic cough, which offers a "large untapped market," Jeong tells investors in a research note. The analyst believes BLU-5937's "validated target and high selectivity pose" lower the clinical risks and position the drug as a potentially competitive drug for chronic cough. Although BLU-5937's timeline is behind its competitors, if the Phase 2 data in mid-2020 show similar efficacy as competitors but with low taste disturbance, the stock can more than double from current levels, contends Jeong. The analyst sees a "favorable" risk/reward for Bellus Health shares.

BLU Bellus Health
$6.49

0.24 (3.84%)

09/30/19
JEFF
09/30/19
INITIATION
JEFF
Buy
Bellus Health initiated with a Buy at Jefferies
Jefferies started Bellus Health with a Buy rating.
09/30/19
GUGG
09/30/19
INITIATION
Target $12
GUGG
Buy
Bellus Health initiated with a Buy at Guggenheim
Guggenheim analyst Dana Flanders initiated Bellus Health with a Buy and $12 price target.
09/30/19
COWN
09/30/19
INITIATION
COWN
Outperform
Bellus Health initiated with an Outperform at Cowen
Cowen analyst Ritu Baral initiated Bellus Health with an Outperform based on its promising drug candidate in the potential blockbuster chronic cough market. The analyst said the drug currently in Phase 2 trial has a high likelihood of statistical success and is modeled to have $833M peak sales in the US.
09/30/19
GUGG
09/30/19
INITIATION
Target $12
GUGG
Buy
Guggenheim starts Bellus Health at Buy with $12 price target
As previously reported, Guggenheim analyst Dana Flanders initiated Bellus Health (BLU) with a Buy rating and $12 price target. BLU-5937 for refractory chronic cough is the primary value driver in "a potential multi-billion dollar category," said Flanders, who also sees the opportunity for label expansion and the potential for M&A interest in Bellus. Merck (MRK) acquired Afferent, which also has a P2X3 antagonist asset called gefapixant, in 2016 for $500M upfront and up to $1.25B with milestones, noted Flanders.

TODAY'S FREE FLY STORIES

WWR

Westwater Resources

$2.50

-0.025 (-0.99%)

, UUUU

Energy Fuels

$2.14

0.24 (12.63%)

10:36
12/05/19
12/05
10:36
12/05/19
10:36
Periodicals
White House panel pushes U.S. to buy uranium from U.S. miners, Bloomberg says »

A White House task force…

WWR

Westwater Resources

$2.50

-0.025 (-0.99%)

UUUU

Energy Fuels

$2.14

0.24 (12.63%)

URG

UR-Energy

$0.59

0.0526 (9.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNP

TEN, Ltd.

$3.52

0.05 (1.44%)

10:35
12/05/19
12/05
10:35
12/05/19
10:35
Hot Stocks
TEN, Ltd. announces charter extension for LNG carrier »

TEN announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$14.68

-0.735 (-4.77%)

10:35
12/05/19
12/05
10:35
12/05/19
10:35
Options
Chemours put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

KELYA

Kelly Services

$21.54

0.11 (0.51%)

, KELYB

Kelly Services

$23.00

(0.00%)

10:34
12/05/19
12/05
10:34
12/05/19
10:34
Hot Stocks
Kelly Services announces agreement to sell, lease back corporate headquarters »

Kelly Services has…

KELYA

Kelly Services

$21.54

0.11 (0.51%)

KELYB

Kelly Services

$23.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLNCY

Glencore

$0.00

(0.00%)

10:31
12/05/19
12/05
10:31
12/05/19
10:31
Hot Stocks
SFO confirms investigation into suspected bribery at Glencore »

Earlier, the U.K. Serious…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPNT

LifePoint

$0.00

(0.00%)

, UHS

Universal Health

$141.30

0.37 (0.26%)

10:31
12/05/19
12/05
10:31
12/05/19
10:31
Periodicals
Hospital groups sue to stop Trump price-transparency requirement, WSJ says »

Hospital groups are suing…

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$141.30

0.37 (0.26%)

THC

Tenet

$33.94

0.21 (0.62%)

CYH

Community Health

$3.21

0.005 (0.16%)

HCA

HCA Healthcare

$139.89

-0.72 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$12.23

0.035 (0.29%)

10:30
12/05/19
12/05
10:30
12/05/19
10:30
General news
EIA natural gas storage change for week ending November 29 »

Gas inventories 19 Bcf…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$18.40

-0.29 (-1.55%)

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Options
L Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 27

    Feb

10:25
12/05/19
12/05
10:25
12/05/19
10:25
General news
Treasury Action: yields remains modestly cheaper »

Treasury Action: yields…

ALT

Altimmune

$2.22

0.07 (3.26%)

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Conference/Events
Altimmune to hold a KOL conference call »

Management holds a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

BIIB

Biogen

$287.05

-2.3 (-0.79%)

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Conference/Events
Biogen to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

FB

Facebook

$199.20

0.5 (0.25%)

10:23
12/05/19
12/05
10:23
12/05/19
10:23
On The Fly
Street Fight: Analysts diverge on Facebook over regulatory issues, core business »

Shares of Facebook (FB)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

FB

Facebook

$199.20

0.5 (0.25%)

, NKE

Nike

$95.12

1.4 (1.49%)

10:22
12/05/19
12/05
10:22
12/05/19
10:22
On The Fly
Mixed Facebook views, 'conviction' in Nike among today's top Wall Street calls »

Check out today's top…

FB

Facebook

$199.20

0.5 (0.25%)

NKE

Nike

$95.12

1.4 (1.49%)

GOOGL

Alphabet Class A

$1,318.54

-0.45 (-0.03%)

GOOG

Alphabet

$1,320.00

-1.46 (-0.11%)

AAPL

Apple

$263.80

2.02 (0.77%)

ETSY

Etsy

$39.93

-2.25 (-5.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 19

    Dec

10:20
12/05/19
12/05
10:20
12/05/19
10:20
General news
FX Action: The dollar »

FX Action: The dollar was…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/05/19
12/05
10:17
12/05/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/05/19
12/05
10:16
12/05/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/05/19
12/05
10:15
12/05/19
10:15
General news
U.S. factory orders increased 0.3% in October »

U.S. factory orders…

10:15
12/05/19
12/05
10:15
12/05/19
10:15
General news
Breaking General news story  »

Week of 11/29 EIA Natural…

10:15
12/05/19
12/05
10:15
12/05/19
10:15
General news
Breaking General news story  »

Week of 11/29 EIA Natural…

SAGE

Sage Therapeutics

$68.03

-81.19 (-54.41%)

10:14
12/05/19
12/05
10:14
12/05/19
10:14
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETN

Eaton

$91.29

0.17 (0.19%)

10:13
12/05/19
12/05
10:13
12/05/19
10:13
Conference/Events
JPMorgan U.S. machinery analyst to hold an analyst/industry conference call »

U.S. Machinery Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BUD

AB InBev

$79.02

-0.35 (-0.44%)

10:10
12/05/19
12/05
10:10
12/05/19
10:10
Options
Call sale in Anheuser Busch exits four-month trade for 99% loss »

Call sale in Anheuser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CONE

CyrusOne

$60.90

-4.22 (-6.48%)

10:10
12/05/19
12/05
10:10
12/05/19
10:10
Periodicals
CyrusOne hit by ransomware attack, ZDNet reports »

Data center provider…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

VOLVY

Volvo

$0.00

(0.00%)

10:08
12/05/19
12/05
10:08
12/05/19
10:08
Hot Stocks
Volvo Group Venture Capital invests in Apex.AI, terms not disclosed »

Volvo Group Venture…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.